ESPE2024 Poster Category 2 GH and IGFs (22 abstracts)
KCMH, Bangkok, Thailand
Introduction: Currently, there is no diagnostic gold standard for growth hormone deficiency (GHD). The diagnosis of GHD is based on the current consensus guidelines, which state that an inadequate GH level of 7 ng/mL during two growth hormone stimulation tests (GHSTs) is indicative of GHD. The primary objectives of this study were to assess the sensitivity and specificity of low IGF-1 levels in combination with a single insulin tolerance test (ITT) for diagnosing GHD.
Methods: This cross-sectional study analyzed data from 131 children aged 1-16 years with short stature who underwent GHSTs. We compared the diagnostic value of IGF-1 levels using a cut-off value of ≤ 0, -1 and -2 SD score, along with the results of a single ITT. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and the area under the curve (AUC) were evaluated.
Results: Among the 131 children, 98 (74.8%) had an IGF-1 SDS ≤ -1 (median -2.05, IQR -2.80 to -1.49), while 33 (25.2%) had an IGF-1 SDS level > -1 (median 0.08, IQR -0.70 to -0.46). GHD was diagnosed in 46 patients (46.9%) in IGF-1 SDS ≤ -1 group, and 14 patients (42.4%) in IGF-1 SDS > 1 group. Combining an IGF-1 level of ≤0 SDS, ≤ -1 SDS, or ≤ -2 SDS with the results of a single ITT yielded specificities of 71.1%, 66.7%, and 77.8%, respectively. The area under the curve (AUC) of the receiver operating characteristic (ROC) curve was 0.94, 0.92, and 0.99, respectively.
Variable | Sensitivity (95% CI) | Specitivity (95% CI) | PPV (95% CI) | NPV (95% CI) | ROC area (95% CI) | P-value |
IGF-1 ≤ 0 SDs + ITT | 94.9 (84.6-98.9) | 71.1 (56.9-82.7) | 74.0 (60.7-84.6) | 94.1 (82.4-98.8) | 0.94 (0.89-0.98) | <0.001‡ |
IGF-1 > 0 SDs + ITT | 100.0 | 66.7 (28.6-92.3) | 80.0 (49.7-95.6) | 100.0 | 0.79 (0.52-1.00) | 0.006‡ |
IGF-1 ≤ -1 SDs + ITT | 94.1 (82.4-98.8) | 66.7 (50.5-80.3) | 72.7 (58.4-84.1) | 92.3 (77.5-98.4) | 0.929 (0.87-0.98) | <0.001‡ |
IGF-1 > -1 SDs + ITT | 100.0 | 80.0 (55.6-94.0) | 81.3 (57.9-94.4) | 100.0 | 0.910 (0.79-1.00) | <0.001‡ |
IGF-1 ≤ -2 SDs + ITT | 100.0 | 77.8 (55.4-92.0) | 86.2 (70.5-95.2) | 100.0 | 0.99 (0.95-1.00) | <0.001‡ |
IGF-1 > -2 SDs + ITT | 90.9 (73.9-98.1) | 66.7 (49.7-80.8) | 64.5 (47.0-79.5) | 91.7 (75.9-98.2) | 0.84 (0.74-0.95) | <0.001‡ |
‡ P < 0.05 (statistic significant) |
Conclusion: When used in combination with the results of a single ITT, low IGF-1 values (≤ 0, ≤ -1, or ≤ -2 SDS) showed suboptimal diagnostic accuracy for GHD.